ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDUARDO CUEVAS MD

Internal Medicine

4,188

$279K

176
127 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $56

ROBERT PETERSON MD

Internal Medicine

5,434

$306K

223
142 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

WALLACE HODGES MD

Internal Medicine

9,073

$764K

287
167 are 65+

38%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$84
Average prescription price

Avg: $56

DIANA VELIKOVA M.D.

Internal Medicine

6,742

$421K

484
404 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

WEI-HSUNG LIN MD

Internal Medicine

6,176

$381K

502
344 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

JACK MORPER M.D.

Internal Medicine

4,184

$137K

273
228 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $56

NICHOLAS CARULLI MD

Internal Medicine

4,027

$326K

210
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $56

DAN GRINSTEAD M.D.

Internal Medicine

5,949

$299K

303
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

FRANK MITCHELL MD

Internal Medicine

4,837

$273K

313
285 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

DEBORAH MEYERS MD

Internal Medicine

587

$66.7K

86
61 are 65+

53%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$114
Average prescription price

Avg: $56

VICKI FISHFADER

Internal Medicine

3,727

$257K

237
206 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $56

SARAH LUX MD

Internal Medicine

4,443

$263K

299
253 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

SOON KIMM M.D.

Internal Medicine

6,010

$309K

166
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

MARY BADGER DO

Internal Medicine

7,614

$356K

337
290 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

DOUGLAS PORTELANCE MD

Internal Medicine

4,170

$221K

227
195 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

ROBERT WIDROW MD

Internal Medicine

6,065

$388K

359
307 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $56

ANNE TUTTLE MD

Internal Medicine

2,798

$158K

241
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

KHUE DUNG NGUYEN MD

Internal Medicine

6,126

$401K

268
235 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $56

BRADLEY HARRIS M.D.

Internal Medicine

8,784

$542K

669
593 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

KIM PRUESS NEVINS MD

Internal Medicine

2,229

$132K

179
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

EILEEN OLINGER MD

Internal Medicine

8,238

$460K

424
381 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

BRYAN MURRAY M.D.

Internal Medicine

6,443

$334K

388
352 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

NANCY CONNOLLY M.D., M.P.H.

Internal Medicine

1,633

$129K

166
119 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$79
Average prescription price

Avg: $56

CORIE SANDALL MD

Internal Medicine

10,950

$835K

507
373 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $56

ANA MIHALCEA MD

Internal Medicine

8,105

$346K

615
558 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank